Shopping Cart
- Remove All
- Your shopping cart is currently empty
LTV-1 has the potential for autoimmunity treatment. LTV-1 is a potent lymphoid tyrosine phosphatase (LYP) inhibitor in T cells with an IC50 of 508 nM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $688 | 6-8 weeks | |
50 mg | $913 | 6-8 weeks | |
100 mg | $1,390 | 6-8 weeks |
Description | LTV-1 has the potential for autoimmunity treatment. LTV-1 is a potent lymphoid tyrosine phosphatase (LYP) inhibitor in T cells with an IC50 of 508 nM. |
Targets&IC50 | LYP (T cells):508 nM |
In vitro | LTV-1 is not cytotoxic in HeLa cells, Jurkat TAg T cells and peripheral blood mononuclear cells (PBMC)[1].even at the highest concentration tested (40 μM). |
Molecular Weight | 472.51 |
Formula | C26H20N2O5S |
Cas No. | 347379-29-7 |
Relative Density. | 1.45 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (105.82 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.